Daniel Nussbaum, MD, is one of 12 investigators to have been selected by National Cancer Institute for their Early-Stage Surgeon Scientist Program (ESSP).
The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.